These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38154249)

  • 1. Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history of stroke.
    Yamada T; Tanaka E; Kishitani T; Kojima Y; Nakashima D; Kitaoji T; Teramukai S; Nagakane Y
    J Neurol Sci; 2024 Jan; 456():122857. PubMed ID: 38154249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior antiplatelet use and infarct volume in ischemic stroke.
    Ovbiagele B; Buck BH; Liebeskind DS; Starkman S; Bang OY; Ali LK; Villablanca JP; Salamon N; Yun SW; Pineda S; Saver JL
    J Neurol Sci; 2008 Jan; 264(1-2):140-4. PubMed ID: 17854835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Tsopozidi M; Savopoulos C; Hatzitolios AI
    Cerebrovasc Dis; 2016; 41(5-6):226-32. PubMed ID: 26795462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premorbid antiplatelet use and ischemic stroke outcomes.
    Sanossian N; Saver JL; Rajajee V; Selco SL; Kim D; Razinia T; Ovbiagele B
    Neurology; 2006 Feb; 66(3):319-23. PubMed ID: 16382033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antiplatelet therapy with lower risk of death and recurrent cerebrovascular events after ischemic stroke--results from the China Ischemic Stroke Registry Study.
    Ding D; Lu CZ; Fu JH; Hong Z;
    Circ J; 2009 Dec; 73(12):2342-7. PubMed ID: 19822978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prestroke antiplatelet agents in first-ever ischemic stroke: clinical effects.
    Jung JM; Choi J; Eun MY; Seo WK; Cho KH; Yu S; Oh K; Hong S; Park KY
    Neurology; 2015 Mar; 84(11):1080-9. PubMed ID: 25672919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke.
    Xian Y; Xu H; Matsouaka R; Laskowitz DT; Maisch L; Hannah D; Smith EE; Fonarow GC; Bhatt DL; Schwamm LH; Mac Grory B; Feng W; Fosbøl EL; Peterson ED; Johnson M
    JAMA Netw Open; 2022 Jul; 5(7):e2224157. PubMed ID: 35900761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative antithrombotic treatment in acutely symptomatic carotid artery stenosis.
    Martinez-Gutierrez JC; Roy AT; D'Amato S; Berkman JM; Montes D; Kimball CA; Rordorf GA; Chibnik LB; Romero JM; Silverman SB
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106396. PubMed ID: 35219972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
    Bhatia K; Ladd LM; Carr KH; Di Napoli M; Saver JL; McCullough LD; Hosseini Farahabadi M; Alsbrook DL; Hinduja A; Ortiz Garcia JG; Sabbagh SY; Jafarli A; Divani AA
    Curr Neurol Neurosci Rep; 2023 May; 23(5):235-262. PubMed ID: 37037980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute Ischemic stroke.
    Mowla A; Sharifian-Dorche M; Mehla S; Lail NS; Sharifian-Dorche A; Vaughn CB; Sawyer RN; Shirani P
    J Neurol Sci; 2021 Jun; 425():117451. PubMed ID: 33882341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
    Shoamanesh A; Mundl H; Smith EE; Masjuan J; Milanov I; Hirano T; Agafina A; Campbell B; Caso V; Mas JL; Dong Q; Turcani P; Christensen H; Ferro JM; Veltkamp R; Mikulik R; De Marchis GM; Robinson T; Lemmens R; Stepien A; Greisenegger S; Roine R; Csiba L; Khatri P; Coutinho J; Lindgren AG; Demchuk AM; Colorado P; Kirsch B; Neumann C; Heenan L; Xu L; Connolly SJ; Hart RG;
    Lancet; 2022 Sep; 400(10357):997-1007. PubMed ID: 36063821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke.
    Marsden K; Mak HY; Crooks CP; Pankaj P; Nguyen T; Tirschwell D
    Curr Cardiol Rep; 2021 Aug; 23(10):145. PubMed ID: 34410542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin and dual antiplatelet therapy for the prevention of early neurological deterioration and recurrent stroke in branch atheromatous disease: a protocol for a prospective single-arm study using a historical control for comparison.
    Huang YC; Lee JD; Weng HH; Lin LC; Tsai YH; Yang JT
    BMJ Open; 2021 Nov; 11(11):e054381. PubMed ID: 34836908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Oral Antiplatelet Agents and Tirofiban on Functional Outcomes of Patients with Non-Disabling Minor Acute Ischemic Stroke.
    Wang H; Li X; Liu C; Huang S; Liang C; Zhang M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104829. PubMed ID: 32689578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
    Kasner SE; Thomassen L; Søndergaard L; Rhodes JF; Larsen CC; Jacobson J
    Int J Stroke; 2017 Dec; 12(9):998-1004. PubMed ID: 29090661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.